Browsing eNauka
Browsing by Author Matytsina, Irina
Showing results 1 to 11 of 11
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2018 | A New Dosing Model Based on Body Mass Index to Guide Factor VIII Dosing in Patients with Hemophilia A | Tiede, Andreas; Goldmann, Georg; Miljic, Predrag S; Korsholm, Lars; Matytsina, Irina; Persson, Paula; Jelev, Lissitchkov Toshko | Conference Paper | Mp. category will be shown later |
| 2020 | Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A | Tiede, Andreas; Rosa, Cid Ana; Goldmann, Georg; Jimenez-Yuste, Victor; Pluta, Michael; Lissitchkov, Toshko; May, Marcus; Matytsina, Irina; Miljic, Predrag S; Pabinger, Ingrid;
Persson, Paula;
| Article | 21aM21a |
| 2014 | Changes in Annualized Bleeding Rate over Time and Relationship with Dosing of Turoctocog Alfa during the guardian(TM) Program![]() | Landorph, Andrea; Santagostino, Elena; Zeuthan, Niels; Ozelo, Margareth Castro; Matytsina, Irina; Janic, Dragana M | Conference Paper | Mp. category will be shown later |
| 2015 | Changes in Annualized Bleeding Rate Over Time and Relationship with Dosing of Tutoctocog a During the Guardian Program![]() | Mancuso, ME; Ozelo, M; Janic, Dragana M | Conference Paper | Mp. category will be shown later |
| 2016 | Efficacy and safety of turoctocog alfa for prophylaxis and treatment of bleeding episodes in patients with severe hemophilia A: results from the guardian (TM) 2 trial![]() | Janic, Dragana M | Conference Paper | Mp. category will be shown later |
| 2018 | Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial![]() | Lentz, Steven R; Janic, Dragana M
Matytsina, Irina; Tiede, Andreas;
| Научни чланак | 21M21 - Водећи међународни часопис категорије M21 |
| 2015 | PO251-WED Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A![]() | Lentz, SR; Kempton, CL; Janic, Dragana M
Matytsina, Irina; Zeuthen, N; Santagostino, E;
| Conference Paper | Mp. category will be shown later |
| 2015 | Prior Treatment Regimen Influences Annualised Bleeding Rate During Long- Term Prophylaxis With Turoctocog Alfa: Experiences From Multinational Trials | Laguna, P; Savic, Aleksandar D | Conference Paper | Mp. category will be shown later |
| 2015 | Safety of Turoctocog Alfa for The Prevention and Treatment of Bleeds in Patients with Haemophilia A: Results for The Guardian (TM) Clinical Trials![]() | Matytsina, Irina; Janic, Dragana M | Conference Paper | Mp. category will be shown later |
| 2017 | Spontaneous Bleeding Rate On Turoctocog Alfa Prophylaxis in a Large Cohort of Patients With Haemophilia A Followed For up to 5 Years - Trends Over Time and Across Geography![]() | Santagostino, E; Martin, Salces M; Lejniece, Sandra; Janic, Dragana M | Conference Paper | Mp. category will be shown later |
| 2018 | Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2![]() | Tiede, Andreas; Janic, Dragana M | Conference Paper | Mp. category will be shown later |
